Skip to main content
UC Davis Cancer Care Network

UC Davis Cancer Care Network

News releases

October 2014arrow

Anti-cancer drug found effective against common stem cell transplant complication

October 24, 2014

Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants.

Distinguished cancer prevention researcher to lead public health sciences at UC Davis

October 21, 2014

Brad Pollock, a leading researcher on the incidence and control of childhood and adolescent cancer, has become chair of the Department of Public Health Sciences at the UC Davis School of Medicine.

NCI awards UC Davis $1.5 million to innovate robotic surgery for head and neck cancers

October 21, 2014

The National Cancer Institute (NCI) has awarded UC Davis principal investigators Laura Marcu and Gregory Farwell $1.5 million to adapt UC Davis-developed biophotonic technology to a robotic surgical device in hopes of dramatically improving the precision of head and neck cancer surgery.

UC Davis to host first BRA Day event

October 13, 2014

To ensure women are aware of their breast reconstruction options, on Oct. 15, from 11 a.m. to 2:30 p.m., the UC Davis Division of Plastic Surgery will host Breast Reconstruction Awareness (BRA) Day at the UC Davis Comprehensive Cancer Center.

Cancer Center wins $1.7 million NCI grant to study novel cancer treatment

October 10, 2014

A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective.

September 2014arrow

Cancer center's Brain Innovation Group funded for brain tumor tool

September 24, 2014

The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology.

Pushing past cancer

September 18, 2014

Special event targeting young cancer survivors ages 15-39 to be held on Nov. 8, 2014 at the UC Davis Comprehensive Cancer Center, 2279 45th St., Sacramento from 10 a.m. to 4:30 p.m.

UC Davis to recognize Breast Reconstruction Awareness (BRA) Day on Oct. 15

September 18, 2014

The UC Davis Comprehensive Cancer Center is sponsoring a day of interactive, informative event to recognize the brave face of each woman with breast cancer on Oct. 15, 2014 from 11 a.m. to 2 p.m. at the cancer center, 4501 X St., Sacramento.

UC Davis-developed target leukemia treatment shows promise

September 11, 2014

Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective.

August 2014arrow

Introducing the multi-tasking nanoparticle

August 26, 2014

mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications.

California isn't measuring up in the fight against cancer

August 21, 2014

In a media briefing at the UC Davis Comprehensive Cancer Center, the American Cancer Society Cancer Action Network released How Do You Measure Up?, an annual report that scores each state on how they are doing in the fight against cancer.

Novel drug action against solid tumors explained

August 11, 2014

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells.

Pan awarded grant to test 'smart' chemotherapy drug for bladder cancer

August 7, 2014

UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients.

July 2014arrow

UC Davis researcher receives NSFC grant to find new gastric cancer genes

July 18, 2014

No Stomach for Cancer Foundation (NSFC) has awarded cancer geneticist Luis Carvajal-Carmona a $50,000 grant to study the genetic characteristics of gastric cancer.

Neural stem cell discovery may aid in treatment research for deafness

July 15, 2014

Researchers at UC Davis School of Medicine have for the first time shown that a polysialylated glycoprotein that regulates neurodevelopment exists on the surface of cells in the adult inner ear.

New combination drug controls tumor growth and metastasis in mice

July 14, 2014

Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor’s ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences.

Pancreatic surgery complications impact hospital costs more than length of stay

July 10, 2014

When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers.

June 2014arrow

Surgical biopsy proves safe for selected late-stage lung cancer patients

June 26, 2014

Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR).

Cancer Center's specialty pharmacy program helps patients adhere to oral chemotherapy

June 24, 2014

A UC Davis program designed to better manage cancer patients taking oral chemotherapy drugs has demonstrated that one-on-one counseling, education and monitoring can improve adherence to potentially life-saving cancer treatments.

Groundbreaking lung cancer trial launched

June 16, 2014

UC Davis Comprehensive Cancer Center patients will soon be part of an unprecedented clinical trial designed to improve access to promising therapies and speed development of effective treatments for an advanced form of lung cancer, the leading cancer killer of both men and women.

UC Davis faculty share cancer research innovation with partners in Madrid

June 11, 2014

UC Davis Comprehensive Cancer Center researchers take center stage this week in Madrid during the second in a series of workshops designed to enhance cultural, academic, scientific and business relations between UC Davis and Madrid.

May 2014arrow

UC Davis professor selected to work with international team on cancer

May 29, 2014

Paramita Ghosh, a UC Davis associate professor and expert in signal transduction pathways in prostate cancer, has been selected as one of 350 scientists to work on a project that aims to reduce public exposure to environmental agents that can lead to cancer and that hopes to inspire research into multi-faceted approaches to cancer prevention, treatment and prolonged survival.

Tailored intervention has low impact on colorectal cancer screening

May 12, 2014

Colorectal cancer screening saves lives, but too few people get tested. In an effort to increase these numbers,researchers from UC Davis and elsewhere investigated whether an individualized interactive multimedia computer program (IMCP) would spur patients to get screened.

April 2014arrow

Dual Role: Key cell division proteins also power up mitochondria

April 17, 2014

An international team led by researchers at UC Davis has shown that the cyclin B1/Cdk1 protein complex, which plays a key role in cell division, also boosts the mitochondrial activity to power that process. This is the first time the complex has been shown to perform both jobs. This newfound ability could make cyclin B1/Cdk1 an excellent target to control cellular energy production, potentially advancing cancer care and regenerative medicine. The research was published online today in the journal Developmental Cell.

UC Davis personalizing outreach to address Asian cancer health disparities

April 11, 2014

In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer patient.

March 2014arrow

Time, trust and transparency keys to minority biospecimen collection

March 26, 2014

Blood and tumor specimen collection from cancer patients is critical to research into new, more personally targeted therapies. But biospecimen collection among diverse populations lags far behind that of whites. [Chinese, Vietnamese and Spanish]

UC Davis physician featured in national health equity project

March 24, 2014

UC Davis professor Christopher Bowlus of the Division of Gastroenterology and Hepatology, and his liver cancer disparity research, are featured on the Health Equity Research Snapshot of the Association of American Medical Colleges (AAMC).

Nine-year effort concludes to fund breast cancer endowment at UC Davis

March 21, 2014

After nine years and countless fund-raising events, the Placer Breast Cancer Endowment on Thursday reached its goal of $1.5 million for breast cancer research at UC Davis Comprehensive Cancer Center.

Potential lung cancer vaccine shows renewed promise

March 20, 2014

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.

UC Davis faculty drive efforts to improve CT safety

March 19, 2014

UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies. The recommendations are detailed in papers published in the March issue of the Journal of the American College of Radiology (JACR).

Minority clinical trials participation and analysis still lag 20 years after federal mandate

March 18, 2014

Twenty years after Congress mandated that research funded by the National Institutes of Health include minorities, less than 5 percent of trials participants are non-white, and less than 2 percent of clinical cancer research studies focus on non-white ethnic or racial groups, UC Davis researchers have found. [Chinese, Spanish, Korean, Vietnamese]

Joint cancer center study finds barriers to minority clinical trial participation

March 18, 2014

A new study involving researchers from UC Davis and four other National Cancer Institute-designated cancer centers reveals important barriers that limit minority group participation in cancer clinical trials, findings that will be used to refine and launch more effective strategies to assure that more minorities benefit from clinical trials.

UC Davis nursing school hopes to improve care for cancer patients with social network

March 14, 2014

Several chemotherapy patients at the UC Davis Comprehensive Cancer Center will be invited to use tablets with a unique social networking tool as part of their treatment plan.

UC Davis researchers one step closer to ovarian cancer marker

March 10, 2014

The hunt is on to find biomarkers that detect cancer, but it’s a challenging process. Early successes often are followed by heartbreaking failures.

Bone turnover markers predict prostate cancer outcomes

March 7, 2014

Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found.

January 2014arrow

Bruce Hammock receives 2014 Brodie Award

January 23, 2014

Bruce D. Hammock, UC Davis Distinguished Professor of Entomology, has received the 2014 Bernard B. Brodie Award from The American Society for Pharmacology and Experimental Therapeutics (ASPET).

James Purdy receives MD Anderson Distinguished Alumnus Award

January 23, 2014

James A. Purdy, UC Davis professor emeritus in the UC Davis Department of Radiation Oncology, has been given the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center.

December 2013arrow

Detecting gastric cancer early -- it's in the sugars

December 20, 2013

Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent.

Survival rates have not improved for metastatic prostate cancer

December 18, 2013

Since the prostate specific antigen (PSA) test was introduced in the late 1980s, prostate cancer mortality has dropped by more than 40 percent. However, there has been tremendous controversy over whether the PSA test has caused that decline.  In a newly published study, UC Davis researchers suggest that PSA screening likely plays an important role. [en español]   

Hybrid clotting factor means fewer injections, better disease control for hemophilia patients

December 12, 2013

A Phase III clinical trial led by UC Davis researchers has confirmed that a new coagulation factor (rFIXFc) dramatically reduces the number of injections needed to maintain effective clotting for hemophilia B patients.

Better guidelines, coordination needed for prostate cancer specialists

December 9, 2013

With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate cancer experts. [en español]

November 2013arrow

Health insurance increases preventive care but not risky behaviors

November 22, 2013

People with health insurance are more likely to use preventive services such as flu shots and health screenings to reduce their risk of serious illness, but they are no more likely than people without health insurance to engage in risky health behaviors such as smoking or gaining weight, researchers at UC Davis and University of Rochester have found. [en español]